18257781|t|Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease.
18257781|a|BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD), which is caused by mutations in polycystins 1 (PC1) and 2 (PC2), is one of the most commonly inherited renal diseases, affecting ~1 : 1000 Caucasians. MATERIALS AND METHODS: We screened Greek ADPKD patients with the denaturing gradient gel electrophoresis (DGGE) assay and direct sequencing. RESULTS: We identified a patient homozygous for a nucleotide change c.1445T > G, resulting in a novel homozygous substitution of the non-polar hydrophobic phenylalanine to the polar hydrophilic cysteine in exon 6 at codon 482 (p.F482C) of the PKD2 gene and a de-novo PKD1 splice-site variant IVS21-2delAG. We did not find this PKD2 variant in a screen of 280 chromosomes of healthy subjects, supporting its pathogenicity. The proband's parents did not have the PKD1 mutation. Real-time PCR of the PKD2 transcript from a skin biopsy revealed 20-fold higher expression in the patient than in a healthy subject and was higher in the patient's peripheral blood mononuclear cells (PBMCs) than in those of her heterozygote daughter and a healthy subject. The greater gene expression was also supported by Western blotting. Inner medullar collecting duct (IMCD) cells transfected with the mutant PKD2 mouse gene presented a perinuclear and diffuse cytoplasmic localization compared with the wild type ER localization. Patch-clamping of PBMCs from the p.F482C homozygous and heterozygous subjects revealed lower polycystin-2 channel function than in controls. CONCLUSIONS: We report for the first time a patient with ADPKD who is heterozygous for a de novo PKD1 variant and homozygous for a novel PKD2 mutation.
18257781	20	24	PKD1	GeneOrGeneProduct	5310
18257781	49	53	PKD2	GeneOrGeneProduct	5311
18257781	87	131	autosomal dominant polycystic kidney disease	DiseaseOrPhenotypicFeature	D007690
18257781	145	189	Autosomal dominant polycystic kidney disease	DiseaseOrPhenotypicFeature	D007690
18257781	191	196	ADPKD	DiseaseOrPhenotypicFeature	D007690
18257781	231	244	polycystins 1	GeneOrGeneProduct	5310
18257781	246	249	PC1	GeneOrGeneProduct	5310
18257781	258	261	PC2	GeneOrGeneProduct	5311
18257781	302	316	renal diseases	DiseaseOrPhenotypicFeature	D007674
18257781	391	396	ADPKD	DiseaseOrPhenotypicFeature	D007690
18257781	397	405	patients	OrganismTaxon	9606
18257781	516	523	patient	OrganismTaxon	9606
18257781	559	570	c.1445T > G	SequenceVariant	rs75762896
18257781	646	716	phenylalanine to the polar hydrophilic cysteine in exon 6 at codon 482	SequenceVariant	rs75762896
18257781	718	725	p.F482C	SequenceVariant	rs75762896
18257781	734	738	PKD2	GeneOrGeneProduct	5311
18257781	758	762	PKD1	GeneOrGeneProduct	5310
18257781	783	795	IVS21-2delAG	SequenceVariant	c|DEL|IVS21-2|AG
18257781	818	822	PKD2	GeneOrGeneProduct	5311
18257781	952	956	PKD1	GeneOrGeneProduct	5310
18257781	988	992	PKD2	GeneOrGeneProduct	5311
18257781	1065	1072	patient	OrganismTaxon	9606
18257781	1121	1128	patient	OrganismTaxon	9606
18257781	1380	1384	PKD2	GeneOrGeneProduct	18764
18257781	1385	1390	mouse	OrganismTaxon	10090
18257781	1535	1542	p.F482C	SequenceVariant	rs75762896
18257781	1595	1607	polycystin-2	GeneOrGeneProduct	5311
18257781	1687	1694	patient	OrganismTaxon	9606
18257781	1700	1705	ADPKD	DiseaseOrPhenotypicFeature	D007690
18257781	1740	1744	PKD1	GeneOrGeneProduct	5310
18257781	1780	1784	PKD2	GeneOrGeneProduct	5311
18257781	Positive_Correlation	c|DEL|IVS21-2|AG	D007690	Novel
18257781	Association	D007690	5311	No
18257781	Association	D007690	5310	No
18257781	Positive_Correlation	rs75762896	D007690	Novel